news

Cannabidiol identified as potential ‘helper’ compound for antibiotics

Researchers have found that using antibiotics in combination with cannabidiol (CBD) enhanced their effect against Staphylococcus aureus bacteria.

Cannabidiol (CBD)

Researchers have revealed that cannabidiol (CBD) could work as a ‘helper’ compound, to enhance the efficacy of antibiotics and reduce the rise of antimicrobial resistance. 

The team, from the University of Southern Denmark, has published a scientific study proving that CBD makes antibiotics more powerful than antibiotics administered by themselves. Therefore, to kill a certain number of bacteria, less antibiotics would be required, they say.

In the study, CBD was used to enhance the effect of the antibiotic bacitracin against Staphylococcus aureus bacteria; a major human pathogen that frequently causes community and hospital-acquired disease.

 

Reserve your FREE place

 


Are low affinity or poor TCR yields slowing you down?

Explore how CHO expression of soluble TCRs and TCR affinity maturation workflows via phage, serving as essential building blocks for early-stage TCR-TCE candidate generation.

22 October 2025 | 16:00 PM BST | FREE Webinar

Join Jiansheng Wu, Ph.D. to explore two integrated strategies:

  • High-titer CHO-based expression of sTCRs (~100 mg/L), enabling scalable and high-throughput production
  • Optimized phage display affinity maturation, improving TCR binding by up to ~10,000-fold

Whether you’re starting a new TCR program or optimizing an existing platform, this session will offer actionable strategies to accelerate discovery and improve candidate quality.

Register Now – It’s Free!

 

The researchers observed three things that happened to the Staphylococcus aureus bacteria when it was treated with the combination of antibiotics and CBD in their study:

  • The bacteria could no longer divide normally
  • The expression of certain key genes (cell division and autolysis genes) in the bacteria was lowered
  • The bacterial membrane became unstable.

“If we combine an antibiotic with a helper compound that enhances the effect of the antibiotic, we need less of the antibiotic to achieve the same effect. This may contribute to the development of fewer resistant bacteria,” explained principal investigator and corresponding author Janne Kudsk Klitgaard.

Therefore, the researchers conclude that the combination of CBD and antibiotics may be a novel treatment of infections with antibiotic resistant bacteria.

The study is published in the journal Scientific Reports.

2 responses to “Cannabidiol identified as potential ‘helper’ compound for antibiotics”

  1. Can you tell us more about this? I’d care to find out some additional information.

  2. I’m amazed, I must say. Rarely do I encounter a blog that’s both educative and engaging, and without a doubt, you’ve hit the nail
    on the head. The problem is something too few folks are speaking intelligently about.
    Now i’m very happy that I found this in my hunt for something regarding this.

Leave a Reply

Your email address will not be published. Required fields are marked *